The objective of this study was to determine whether Gq/11-coupled receptor activation can enhance the mechanosensitivity of a canonical transient receptor potential (TRPC)-like current and consequently the myogenic responsiveness of rat anterior cerebral arteries. Initial patch-clamp experiments revealed the presence of a basal cation current in isolated smooth muscle cells that displayed evidence of double rectification, which was blocked by trivalent cations (Gd 3ϩ and La 3ϩ ). PCR analysis identified the expression of TRPC1, 3, 6 and 7 mRNA and, characteristic of TRPC-like current, the whole-cell conductance was insensitive to a Na ϩ -dependent transport (amiloride), TRP vanilloid (ruthenium red), and chloride channel (DIDS, niflumic acid, and flufenamate) inhibitors. One notable exception was tamoxifen, which elicited a dual effect, blocking or activating the TRPC-like current at 1 and 10 M, respectively. This TRPC-like current was augmented by constrictor agonists (uridine 5=-triphosphate and U46619) or hyposmotic challenge (303 to 223 mOsm/l), a mechanical stimulus. Although each stimulus was effective alone, smooth muscle cells pretreated with agonist did not augment the whole-cell response to hyposmotic challenge. Consistent with these electrophysiological recordings, functional experiments revealed that neither UTP nor U46619 enhanced the sensitivity of intact cerebral arteries to hyposmotic challenge or elevated intravascular pressure. In summary, this study found no evidence that Gq/11-coupled receptor activation augments the mechanosensitivity of a TRPC-like current and consequently the myogenic responsiveness of anterior cerebral arteries.
intravascular pressure; myogenic response; transient receptor potential canonical channels; vascular smooth muscle RESISTANCE ARTERIES FORM AN integrated network that controls the magnitude and distribution of tissue blood flow (35, 36, 41) . Under dynamic conditions, tone within these networks is regulated by multiple stimuli including blood flow (13, 24) , neuronal activity (2, 37) , tissue metabolism (12, 17) , and changes in intraluminal pressure (1, 23) . A century ago, Bayliss (1) first surmised that resistance arteries could respond to changes in intravascular pressure. The so-called myogenic response is observable in a variety of vascular beds and is particularly prominent in the cerebral and renal circulations where constant perfusion must be maintained over a physiological range of systemic blood pressures (1, 19, 28, 38, 40, 41) . Like any given stimulus, intravascular pressure sets arterial tone by altering the phosphorylation state of the myosin regulatory light chain, a process dynamically controlled by myosin light chain kinase and phosphatase (6, 21, 22) . Although the precise mechanism has not been fully elucidated, it is generally recognized that a rise in cytosolic [Ca 2ϩ ] is a key mediating step (22, 23) . This increase in [Ca 2ϩ ] is generally, although not exclusively, linked to the depolarization of arterial smooth muscle and the activation of voltage-operated Ca 2ϩ channels (22, 23, 40, 41) .
On a conceptual level, myogenic depolarization could arise from an augmentation of depolarizing inward current (cation, Ca 2ϩ , or Cl Ϫ channels) (31, 38, 40) and/or inhibition of an outward K ϩ conductance (18) . Although a number of ion channels have been implicated in this physiological response, past investigations have principally focused on nonselective cation channels, particularly those encoded by the superfamily of transient receptor potential (TRP) channels (3, 10) . TRP channels were first identified in Drosophila, and their primary function is to act as cellular sensors of the biological environment (4) . The TRP channel superfamily comprises 28 distinct gene products, and, in vascular smooth muscle, multiple subunits of TRP canonical (TRPC), TRP vanilloid (TRPV), and TRP melastatin (TRPM) subclasses are robustly expressed (9, 15, 30, 42, 43) . Several of these subunits, in particular TRPC6, TRPV2, and TRPM4, appear to exhibit mechanosensitivity and thus, on a conceptual level, could participate in pressureinduced depolarization (9, 11, 14, 40) .
TRPC6 is a six-transmembrane-domain polypeptide subunit that forms homo-and heteromultimeric channels with TRPC3 and TRPC7, which displays a degree of double rectification (4, 20) . In resistance arteries, the first evidence suggesting that TRPC6 was mechanosensitive came from in situ knockdown experiments showing that subunit downregulation coincided with reduced myogenic tone development (40) . These intriguing observations prompted a deeper examination, with TRPC6 expression studies yielding mixed results (16, 20, 39) . This is exemplified by the work of Gottlieb et al. (16) , who on the one hand noted little channel activation to cell stretch, whereas Inoue et al. (20) and Spassova et al. (39) reported modest mechanosensitivity. In addressing this inconsistency, investigations have recently suggested that TRPC6 mechanosensitivity might be intimately linked to G q/11 -couple receptors (20, 34) . In particular, they argued that G q/11 -coupled receptors might be capable of sensitizing TRPC6 to mechanical stimuli either through direct association or cell signaling (20, 34) . The idea that G q/11 -coupled receptors help confer TRPC6 mechanosensitivity is intriguing and one which functionally implies that constrictor agonists could augment the myogenic sensitivity of resistance arteries. Although studies are limited, agonistinduced grading of pressure responses has been previously noted in skeletal muscle resistance arteries (27, 29) .
The goal of this study was to isolate a TRPC-like current and to determine whether G q/11 -coupled receptor activation could enhance its mechanosensitivity along with the myogenic responsiveness of rat cerebral arteries. Electrophysiological measurements performed on smooth muscle cells isolated from anterior cerebral arteries confirmed the presence of a cation current that displayed properties consistent with TPRC channels. G q/11 -coupled receptor agonists (i.e., U46619 or UTP) along with hyposmotic challenge (a mechanical stimulus) augmented the TRPC-like current when applied individually. Pretreating cells with agonist failed to enhance the responsiveness of the whole-cell conductance to hyposmolarity. Consistent with these electrophysiological observations, vasoconstrictor agonists failed to augment the responsiveness of intact cerebral arteries to a hyposmotic challenge or a rise in intravascular pressure. From these findings, we conclude that although G q/11 -coupled receptor activation can modulate TRPC-like currents, it does not enhance the mechanosensitivity of the underlying channels nor the myogenic responsiveness of anterior cerebral arteries.
MATERIALS AND METHODS
Animal procedures and tissue preparation. Animal procedures were approved by the University of Calgary Animal Care and Use Committee. Female Sprague-Dawley rats (10 -12 wk of age; ϳ150 g) were euthanized via carbon dioxide asphyxiation. After euthanasia, the brain was isolated and stored in ice-cold phosphate-buffered (pH 7.4) saline solution containing (in mM) 138 NaCl, 3 KCl, 10 Na 2HPO4, 2 NaH2PO4, 5 glucose, 0.1 CaCl2, and 0.1 MgSO4. Middle and anterior cerebral arteries were carefully dissected free of connective tissue and cut into ϳ2 mm segments.
Isolation of arterial smooth muscle cells. Smooth muscle cells were enzymatically isolated from middle and anterior cerebral arteries as described previously (33) . In brief, arterial segments were equilibrated for 10 min at 37°C in isolation media containing (in mM) 60 NaCl, 80 Na-glutamate, 5 KCl, 2 MgCl 2, 10 glucose, and 10 HEPES with 1 mg/ml albumin (pH 7.4). Tissue samples were subsequently incubated (15 min, 37°C) in the same media supplemented with 0.5 mg/ml papain and 1.5 mg/ml dithioerythritol; this was followed by a 10-min incubation in media containing 100 M Ca 2ϩ , 0.7 mg/ml type F collagenase, and 0.4 mg/ml type H collagenase. Tissues were then washed three times in ice-cold isolation media and triturated with a fire-polished pipette to disperse smooth muscle cells. Cell samples were stored on ice and used the same day.
Electrophysiology. Conventional patch-clamp electrophysiology was used to measure TRPC-like currents as described previously (41) . Patch pipettes were pulled from borosilicate glass and fire-polished to resistances of 4 -7 M⍀. Pipettes were then coated with wax to reduce capacitance and backfilled with pipette solution containing (in mM) 100 NaCl, 90 D-mannitol, 5 HEPES, 5 EGTA, and 5 Mg 2ϩ -ATP (pH 7.2). Cells were voltage clamped at Ϫ60 mV in an isotonic bath solution containing (in mM) 100 NaCl, 90 D-mannitol, 1.5 MgCl2, 10 glucose, and 10 HEPES (pH 7.4). A 1 M NaCl-agar salt-bridge around the reference electrode was used to minimize offset potentials. Wholecell currents were recorded on an Axopatch 200B amplifier (Molecular Devices, MDS Analytical Technologies, Mississauga, ON, Canada), filtered at 1 kHz, digitized at 5 kHz, and analyzed with Clampfit 8.2 software. Typical whole-cell currents were monitored every minute using a voltage ramp protocol (Ϫ100 to ϩ100 mV, 0.66 mV ms Ϫ1 ); quantification was performed at ϩ100 mV and Ϫ100 mV. Cell capacitance was measured with the cancellation circuitry in the voltage-clamp amplifier and averaged 19.1 Ϯ 0.8 pF. Cells were excluded from analysis if cell capacitance shifted more than 0.5 pF. All experiments were performed at room temperature (20 -22°C).
Cells voltage-clamped at Ϫ60 mV were equilibrated for 15 min before experimentation. After equilibration, two sets of experiments were conducted, the first focusing on isolation and characterization of TRPC-like currents. In these experiments, we examined the sensitivity of whole-cell currents to bath solutions in which: 1) [NaCl] was reduced to 60 mM to separate equilibrium potential for Na ϩ (ENa) from equilibrium potential for Cl Ϫ (ECl) or 2) polyvalent cations (Gd 3ϩ , 30 M; La 3ϩ , 100 M; ruthenium red, 1 M), amiloride (100 M), or Cl Ϫ -channel inhibitors (DIDS, 300 M; niflumic acid, 50 M; flufenamate, 100 M; tamoxifen, 1 or 10 M) had been added. A second series of experiments examined the sensitivity of TRPC-like currents to hyposmotic challenge (i.e., a mechanical stimulus) and/or to the G protein-coupled receptor agonists U46619 (10 nM) and UTP (30 M). To make the bath solution hyposmotic (303 to 223 mOsmol/ l), the D-mannitol concentration was decreased from 90 to 10 mM.
RT-PCR analysis. Approximately 300 smooth muscle cells were enzymatically isolated from anterior cerebral arteries and placed in RNase-and DNase-free collection tubes. After total RNA extraction (RNeasy mini kit with DNase treatment; Qiagen, Valencia, CA), first-strand cDNA was synthesized using the Sensiscript RT kit (Qiagen). Subsequently, 2 l of each first-strand cDNA reaction was used as template in a PCR reaction containing 1.5 mM MgCl 2, 0.25 M forward and reverse primers (University of Calgary, Alberta, Canada); 0.2 mM deoxynucleoside triphosphates; and 2.5 U recombinant Taq DNA polymerase. PCR reactions were hot started (94°C for 3 min) and underwent 35 cycles of 94°C for 1.0 min, 60°C for 0.5 min, and 72°C for 0.75 min. PCR samples were then exposed to a final extension period at 72°C for 10 min. Forward (F) and reverse (R) primers specific to rat TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7 were as follows:
; and TRPC7 (F) 5=-GAAGTACGACCACAAGTTCATCG-3=, (R) 5-TCAGGTGGTCTTTGTTCAAAT-3=. The expected amplicon sizes for TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7 were 580, 314, 414, 443, 552, and 649 base pairs, respectively. DNA sequencing was used to identity each reaction product.
Vasomotor measurements. Arterial segments were mounted in a customized arteriograph and superfused with warm (37°C) physiological salt solution (PSS; pH 7.4; 21% O2, 5% CO2, balance N2) containing (in mM) 119 NaCl, 4.7 KCl, 20 NaHCO3, 1.1 KH2PO4, 1.2 MgSO4, 1.6 CaCl2, and 10 glucose. To limit the influence of the endothelium on arterial tone, these cells were removed by passing air bubbles through the vessel lumen (1 to 2 min); successful removal was confirmed by the loss of bradykinin-induced dilation. Arteries were then equilibrated for 30 min at 15 mmHg and contractile responsiveness assessed by briefly exposing (ϳ10 s) tissue to 60 mM KCl. External diameter was monitored using an automated edge detection system (IonOptix, Milton, MA).
Two general sets of experiments were conducted, the first focusing on whether agonist application (10 nM U46619) could enhance arterial responsiveness to hyposmotic challenge. In these experiments, vessels were initially reequilibrated with a modified isosmotic PSS containing (in mM) 79 NaCl, 4.7 KCl, 80 D-mannitol, 20 NaHCO3, 1.7 KH2PO4, 1.2 MgSO4, 1.6 CaCl2, and 10 glucose. After 15 min of equilibration, tissues were exposed (5 min) to PSS rendered hyposmotic (226 mOsmol/l) through the removal of D-mannitol. This protocol was then repeated in the presence of U46619 (10 nM). In the second experimental series, intravascular pressure was increased incrementally from 15 to 100 mmHg while pressureinduced diameter responses were actively monitored. After these control measurements were collected, arteries were returned to 15 mmHg and equilibrated for 5 min with PSS containing: 1) U46619 (10 nM) or UTP (30 M) or 2) zero externally added Ca 2ϩ ϩ 2 mM EGTA (referred to as Ca 2ϩ -free PSS). Vasomotor responsiveness to elevated intravascular pressure was then reassessed. A myogenic index calculated as the diameter change between 20 and 100 mmHg was used to ascertain whether pressure sensitivity was altered by agonist application.
Chemicals, drugs and enzymes. U46619 and tamoxifen were purchased from Calbiochem (La Jolla, CA). Niflumic acid was acquired from MP Biomedicals (Solon, OH). Flufenamate was purchased from Alfa Aesar (Ward Hill, MA). LaCl 3 was obtained from EMD Chemicals (Gibbstown, NJ). Buffer reagents, amiloride, GdCl3, ruthenium red, collagenases (type F and H), and UTP were purchased from Sigma (St. Louis, MO). Papain and DIDS were acquired from Worthington (Lakewood, NJ).
Statistical analyses. Data are expressed as means Ϯ SE, and n indicates the number of vessels or cells. Paired t-tests were performed to statistically compare the effects of a given condition/treatment on Fig. 1 . An outwardly rectifying cation current in smooth muscle cells from middle cerebral arteries. Whole-cell current was monitored using a ramp protocol (Ϫ100 to ϩ100 mV, 66 mV/s). A-C: representative traces and summary data (n ϭ 12) of whole-cell currents in the absence or presence of Gd 3ϩ (30 M). *Significant difference from control. D: representative trace of whole-cell current in a bath solution containing 100 mM (ENa and ECl ϭ 0 mV) or 60 mM (ENa ϭ Ϫ20 mV; ECl ϭ ϩ20 mV) NaCl, where ENa and ECl are equilibrium potential for Na ϩ and Cl Ϫ respectively. Fig. 2 . An inwardly and outwardly rectifying cation current in anterior cerebral arterial smooth muscle cells. Whole-cell current was monitored using a ramp protocol (Ϫ100 to ϩ100 mV, 66 mV/s). A and B: representative whole-cell currents under resting conditions or in bath solution containing 100 mM (ENa and ECl ϭ 0 mV) or 60 mM (ENa ϭ Ϫ20 mV; ECl ϭ ϩ20 mV) NaCl. C: total RNA extracted from 300 anterior cerebral arterial smooth muscle cells was subjected to RT-PCR analysis. mRNA for transient receptor potential canonical (TRPC)1, TRPC3, TRPC6, and TRPC7 subunits was observed. arterial diameter or whole-cell current. If more than two conditions or treatments were being compared, a repeated-measures ANOVA was used. P values Յ0.05 were considered statistically significant.
RESULTS
Whole-cell electrophysiology. This investigation began by monitoring whole-cell currents in smooth muscle cells isolated from middle cerebral arteries. These conventional recordings revealed an outwardly rectifying current sensitive to Gd 3ϩ (Fig. 1, A-C) in which reversal potential shifted leftward in accordance with E Na , as bath [NaCl] was lowered from 100 to 60 mM (Fig. 1D) . Consistent with previous studies (41) , this response was evident at positive voltages, but small and difficult to accurately quantify at negative voltages (Fig. 1C) . Consequently, we screened smooth muscle cells from other areas of the cerebral circulation to identify a vessel source in which inward current was greater in magnitude. In ϳ75% of smooth muscle cells isolated from anterior cerebral arteries, we observed a resting whole-cell current in which: 1) reversal potential (0 to Ϫ20.4 Ϯ 0.4 mV; n ϭ 7) shifted leftward with changes in E Na (0 to Ϫ20.2 mV) and 2) inward component was more prominent, often displaying a modest degree of inward rectification (Fig. 2, A and B) . A PCR screen of anterior cerebral arterial smooth muscle cells revealed mRNA expression of TRPC1, 3, 6, and 7; DNA sequencing was used to confirm product identity (Fig. 2C ). This study found no evidence of TRPC4 or TPRC5 mRNA expression.
We next characterized the pharmacological profile of the basal cation current in smooth muscle cells from anterior cerebral arteries. This examination started with the application of lanthanides and, as shown in Fig. 3, A and B , GdCl 3 (30 M) and LaCl 3 (100 M) strongly inhibited inward and outward currents. Lanthanide-subtracted currents (Fig. 3, C and D) displayed modest double rectification, a property consistent with channels containing TRPC3, TRPC6, and/or TRPC7 subunits. In contrast, ruthenium red (1 M), a purported TRPV Fig. 3 . TRPC-like current in anterior cerebral arterial smooth muscle cells is sensitive to Gd 3ϩ and La 3ϩ . A and B: representative recordings of the TRPC-like current under control conditions and in the presence of Gd 3ϩ (30 M) or La 3ϩ (100 M). C and D: Gd 3ϩand La 3ϩ -sensitive difference currents, respectively. E: summary data on the effects of Gd 3ϩ (n ϭ 30) and La 3ϩ (n ϭ 7) on the inward and outward components of the whole-cell current. *Significant difference from control. channel blocker, had little effect [peak current at Ϫ100 and ϩ100 mV (n ϭ 4): Ϫ1.43 Ϯ 0.15 and 2.85 Ϯ 0.14 pA (control) and Ϫ1.43 Ϯ 0.18 and 2.76 Ϯ 0.12 pA (ruthenium red)]. Likewise, Cl Ϫ channel blockers [DIDS (300 M), niflumic acid (50 M), and flufenamate (100 M) had no discernible effect on the basal TPRC-like current, nor did amiloride (100 M), an inhibitor of Na ϩ -coupled transport systems including the epithelial sodium channel ENaC (Fig. 4, A-E) ]. Intriguingly, tamoxifen, a nonsteroidal triphenylethylene derivative that influences a range of anionic and cationic channels, elicited a dual effect. At 1 M, this agent strongly inhibited the inward and outward components of the resting current (Fig. 5,  A and C) , whereas, at 10 M, tamoxifen induced robust activation, a response that was in turn blocked by Gd 3ϩ (Fig.  5, B and C) . G q/11 -coupled receptors and the modulation of mechanosensitivity in anterior cerebral arteries. Through isolation of a cation conductance in which electrophysiological and pharmacological properties were consistent with TRPC-like channels, this study started to assess its sensitivity to G q/11 -coupled receptor agonists and hyposmotic challenge. Figure 6, A, B , and D, reveals that the application of U46619 (10 nM: a thromboxane A 2 mimetic) or UTP (30 M: a P2Y agonist) enhanced both the inward and outward components of the TRPC-like current. This augmentation occurred within the first 5 min of agent application and was maintained over time (ϳ20 min). A hyposmotic challenge, induced by lowering the bath osmolarity from 303 to 223 mOsm/l, elicited a comparable augmentation (Fig. 6, C and D) over a similar time frame. Figure 6E indicates that the preceding responses were typically observed in 50% of all smooth muscle cells isolated from the anterior cerebral artery. With each stimulus retaining the ability to augment the TRPC-like current, subsequent experiments were undertaken to address whether agonist pretreatment might facilitate the responsiveness of smooth muscle cells to mechanical stimuli. Contrary with expectations (20, 34) , smooth muscle cells pretreated with, and sensitive to, agonists (U46619 or UTP) displayed no augmented responsiveness to hyposmotic challenge ( Fig. 7) . Control experiments confirmed that TRPClike currents activated by U46619 were blocked by La 3ϩ [peak Functional experiments were subsequently performed to assess whether G q/11 -coupled receptor agonists could enhance cerebral arterial responsiveness to mechanical stimuli. Initial work employing a hyposmotic stimulus revealed that an 80 mOsm/l drop in bath osmolarity induced a pronounced constriction of anterior cerebral arteries maintained at 20 mmHg (Fig. 8, A and B) . The subsequent addition of U46619 (10 nM) modestly increased basal tone but did not influence arterial responsiveness to hyposmolarity. It is important to note that the latter measures were not delimited by vasomotor capacity since 60 mM KCl elicited constrictor responses 30% greater than the combined effects of U46619 and hyposmolarity. To address whether agonists could influence myogenic tone, arterial diameter was measured through a range of intravascular pressures, with and without U46619 (10 nM) and UTP (30 M). A myogenic index was then calculated, from the diameter change between 20 and 100 mmHg, as ascertain whether pressure sensitivity was altered. Figure 8 , C-F, indicates that although U46619 and UTP modestly augmented resting tone, the overall nature of the pressure response did not change. Indeed, the myogenic index (Fig. 8G ) surprisingly documented a nonsignificant trend toward reduced pressure sensitivity in the presence of agonist.
DISCUSSION
We identified a TRPC-like current in cerebral arterial smooth muscle cells and sought to determine whether G protein-coupled receptor activation could enhance its mechanosensitivity along with the myogenic responsiveness of intact vessels. An initial examination of anterior cerebral arterial smooth muscle cells revealed a whole-cell cation current with TRPC-like properties as it displayed modest double rectification and was inhibited by trivalent cations (Gd 3ϩ and La 3ϩ ). PCR analysis revealed mRNA expression of TRPC1, TRPC3, TRPC6, and TRPC7, whereas further electrophysiological measurements revealed that Cl Ϫ channel and Na ϩ -dependent transport inhibitors had little effect on the whole-cell current. Tamoxifen was a notable exception: this agent elicited both inhibitory and stimulatory effects depending on the bath concentration. The application of G q/11 -coupled receptor agonists (UTP and U46619) enhanced the TRPC-like current, as did hyposmotic challenge, a known mechano-stimulus (41) . Contrary with expectations (20, 34) , pretreatment of cells with G q/11 -coupled receptor agonists did not enhance the responsiveness of the TRPC-like current to hyposmotic challenge. Functional experimentation also found no evidence that vasoconstrictor agonists augmented the ability of anterior cerebral arteries to constrict in response to hyposmolarity or elevated intravascular pressure. Overall, our findings suggest that although G q/11 -coupled receptor agonists can modulate TRPClike currents in cerebral arterial smooth muscle cells, they do not enhance their mechanosensitivity or the ability of intact arteries to respond to intravascular pressure changes.
Background. Bayliss (1) first described the intrinsic ability of resistance arteries to actively respond to intravascular pressure. The so-called myogenic response is an intrinsic property of vascular smooth muscle cells, and it is prominent in organs where constant perfusion must be maintained over physiological pressures. It is generally recognized that a rise in cytosolic [Ca 2ϩ ] is a key mediating step and that such increases are principally although not exclusively linked to arterial depolarization and the activation of voltage-operated Ca 2ϩ channels (22, 23, 40, 41) . In theory, pressure-induced depolarization could arise from an augmentation of depolarizing inward current (cation, Ca 2ϩ or Cl Ϫ channels) (31, 38, 40) and/or inhibition of an outward K ϩ conductance (18) . Although a number of ion channels have been implicated, recent work has largely focused on nonselective cation channels, particularly those that comprise TRP subunits.
In mammals, the TRP channel superfamily comprises 28 members that are classified into six subfamilies (4, 5) . In vascular smooth muscle, several TRPC, TRPV, and TRPM subunits are expressed and form ion channels thought to be sensitive to mechanical stimuli (3, 9, 11, 24, 43) . The first vascular evidence that TRPC subunits may be mechanosensi-tive came from in situ knockdown experiments in which the downregulation of TRPC6 was found to correlate with attenuated myogenic tone development in the cerebral circulation (40) . Although a provocative observation, expression studies have produced inconsistent results in regard to TRPC6 mechanosensitivity, with some noting this property and others not (16, 20, 39) . In addressing this discrepancy, Inoue et al. (20) along with Schnitzler et al. (34) suggested that mechanosensitivity might require TRPC6 to directly associate with, or be modulated by, G q/11 -coupled receptors. This idea is intriguing and one that has important functional implications. In particular, it suggests that agonists might retain an ability to augment myogenic responsiveness. Such enhancement has been observed previously in skeletal muscle resistance arteries (27, 29) .
Isolation and characterization of a TRPC-like current. It was within this physiological context that we set out to isolate and characterize a TRPC-like current in cerebral arterial smooth muscle cells. Our initial examination centered on smooth muscle cells from middle cerebral arteries, and, consistent with past investigations, we observed an outwardly rectifying cation current sensitive to the trivalent cation Gd 2ϩ (Fig. 1) (41) . The inward component of the whole-cell current, however, was small, difficult to assess, and did not display rectifying properties (7) . Given these concerns, we surveyed other myogenically responsive arteries and discovered that smooth muscle cells from anterior cerebral arteries express a cation current with both outward and inwardly rectifying components (Fig. 2) . PCR analysis confirmed mRNA expression of TRPC1, TRPC3, TRPC6, and TRPC7 and, as one would expect for TRPC-like current, Gd 3ϩ (30 M) and La 3ϩ (100 M) elicited strong inhibitory effects (Fig. 3) . Interestingly, the Gd 2ϩ and La 3ϩ difference currents displayed a degree of inward and outward rectification, a property common to channels retaining TRPC3, TRPC6, and TPRC7 subunits ( Fig. 3 ) and less so TRPV and TRPM. Ruthenium red (1 M), a purported TRPV inhibitor, had little effect on the basal current as did amiloride (100 M), a blocker of Na ϩ -coupled transporters including ENaC (5, 8) . Additional pharmacological profiling showed that the basal TRPC-like current was insensitive to DIDS (300 M) and niflumic acid (50 M), agents commonly used to block swelling-and Ca 2ϩ -activated Cl Ϫ channels (Fig. 4) . It was also insensitive to flufenamate (100 M), a compound that, in addition to blocking Cl Ϫ conductance, has diverse effects on homomeric TRPC channels ranging from the transient activation of TRPC6 to sustained inhibition of TRPC3 and TRPC7 (5) . Indeed, it is intriguing to speculate, based on the absence of a directional effect, that the channels underlying the TRPC-like current may be heteromultimeric in nature. We also observed that tamoxifen, a nonsteroidal triphenylethylene derivative, had a unique dual effect on the basal TRPC-like current. This consisted of inhibition at 1 M followed by a profound 50-fold augmentation of both inward and outward current at a modestly higher concentration (10 M) . Although this investigation is the first to document the dualistic effect of tamoxifen on TRPC-like currents, a similar phenomenon has been reported for large conductance Ca 2ϩ -activated K ϩ channels (BK) (32) . Interestingly, singlechannel recordings of BK channels attributed the bimodal effect of tamoxifen to a number of complex interactions with the pore-forming subunit. This included the induction of two distinct types of block and a unique activator function that involved destabilization of the long closed state (32) .
G protein-coupled receptors and the modulation of mechanosensitivity in anterior cerebral arteries. Having isolated a whole-cell conductance with TRPC-like properties, we subsequently tested whether its mechanosensitivity could be enhanced by G q/11 -coupled receptor agonists and if this augmented response impacted on the myogenic reactivity of intact arteries. This examination began simply by characterizing the individual effects of: 1) U46619 (10 nM) and UTP (30 M) and 2) hyposmotic challenge (303 to 223 mOsmol/l), a mechano-stimulus shown to induce an arterial response similar to intravascular pressure (41) . Figure 6 shows that exposing isolated smooth muscle cells to G q/11 -coupled receptor agonists augmented both the inward and outward components of the TRPC-like cation current. These observations correspond well with past studies and, at a mechanistic level, can be attributed to the activation of phospholipase C-␤, which hydrolyzes phosphatidylinositol-4,5-bisphosphate to generate 1,2-diacylglycerol (25, 26) . Similar to agonists, an 80 mOsm/l hyposmotic challenge augmented the TRPC-like current. Although smooth muscle cells from anterior cerebral arteries were responsive to individual stimuli, agonist pretreatment failed to sensitize the whole-cell current to a hyposmotic challenge (Fig.  7) . One could speculate that the absence of an additive effect indicates that both stimuli are either part of or utilizing a common signaling pathway. This view would be consistent with the findings of Schnitzler et al. (34) , who noted that G q/11 -coupled receptors must be expressed in tandem with TRPC channels in order for mechanical stimuli to actively modulate this conductance. Based on electrophysiological observations, one would functionally predict that G q/11 -coupled receptor agonists are unlikely to synergistically enhance the mechanosensitivity of intact cerebral arteries. Consistent with this prediction, we found that pretreatment of anterior cerebral arteries with U46619 failed to enhance contractile responsiveness to a brief hyposmotic challenge (Fig. 8) . Similarly, preexposing anterior cerebral arteries to a concentration of U46619 (10 nM) or UTP (30 M) that induced baseline tone Fig. 8 . The effect of agonist pretreatment on the contractile responsiveness of anterior cerebral arteries. A: representative trace of hyposmotic constriction in the absence or presence of U46619 (10 nM). B: summary data highlight the effects of agonist pretreatment on hyposmotic constriction (n ϭ 10). C and E: representative traces of pressure-induced constriction in the absence or presence of U46619 (10 nM) or UTP (30 M). D, F, and G: summary data highlighting the effects of U46619 (n ϭ 10) or UTP (n ϭ 9) pretreatment on myogenic tone. To assess pressure sensitivity, a myogenic index was calculated based on the change in arterial tone between 20 and 100 mmHg. *Statistical difference from control. development failed to enhance pressure sensitivity, as denoted by the myogenic index calculation. Indeed, there was a nonsignificant trend in the opposing direction, perhaps suggestive that agonists reduce pressure sensitivity. In presenting these observations, a degree of caution is required with respect to broader interpretation. Findings are limited to the cerebral vasculature and do not preclude constrictor agonists from sensitizing TRPC-like currents or augmenting myogenic tone in other vessel classes [e.g., skeletal muscle (27, 29) ]. Likewise, they do not argue against the complete concept of synergistic interaction among chemical and mechanical stimuli.
Summary. In conclusion, we have identified a whole-cell cation current in anterior cerebral arterial smooth muscle cells that exhibits electrophysiological and pharmacological properties consistent with TRPC channels. We showed that this whole-cell current could be individually activated by G q/11coupled receptor agonists (i.e., U46619 and UTP) and mechanical stimuli (i.e., hyposmotic swelling). Contrary with expectations (20, 34) , we observed no synergy between the defined chemical and mechanical stimuli, since agonist pretreatment did not augment the sensitivity of the TRPC-like current to hyposmotic challenge. This absence of synergy extended to the functional level where agonist application failed to enhance the sensitivity of anterior cerebral arteries to elevated intraluminal pressure. We conclude that although G protein-coupled receptors can modulate TRPC-like currents, they do not enhance the mechanosensitivity of the underlying channels nor the myogenic responsiveness of anterior cerebral arteries.
